Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) recognizing tetanus, diphtheria, and pertussis-derived peptides are specialized heterodimeric surface proteins found on CD4+ T lymphocytes. These receptors specifically bind to antigenic peptides derived from Clostridium tetani toxoid, Corynebacterium diphtheriae toxoid, and Bordetella pertussis components when presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (PubMed, PMID: 28416512). This interaction is the fundamental step in the adaptive immune response triggered by Tdap vaccination, leading to the activation of helper T cells, B-cell maturation, and the production of high-affinity neutralizing antibodies (CDC, 2020). In clinical practice, these TCRs are the primary targets of Tdap vaccines, which aim to establish long-term immunological memory to prevent severe bacterial infections (StatPearls, 2023). Monitoring the frequency and diversity of these TCR clones serves as a critical biomarker for vaccine efficacy and the duration of protective immunity (PubMed, PMID: 31209223). These receptors are essential for the orchestration of both cellular and humoral immunity against these life-threatening toxins.
Antigen-specific activation of CD4+ T cells via MHC class II-mediated peptide presentation, leading to immunological memory and B-cell help.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing tetanus, diphtheria, and pertussis-derived peptides.